Press Release: Dupixent® (dupilumab) late-breaking Phase 3 COPD results presented at ATS and simultaneously published in the New England Journal of MedicineGlobeNewsWire • 05/21/23
Sanofi Applauds Supreme Court Ruling Supporting Scientific Innovation by Striking Down Amgen's Asserted PCSK9 Patent Claims in Amgen v SanofiPRNewsWire • 05/18/23
Sanofi Says Its RSV Shot Significantly Cut Hospitalization Risk In NewbornsInvestors Business Daily • 05/12/23
Press Release: Nirsevimab delivers 83% reduction in RSV infant hospitalizations in a real-world clinical trial settingGlobeNewsWire • 05/12/23
Prescription-drug costs in spotlight as pharmacy benefit reform advances in SenateMarket Watch • 05/11/23
Sanofi: COMBINED GENERAL MEETING OF MAY 25, 2023 - AVAILABILITY OF PREPARATORY DOCUMENTSGlobeNewsWire • 05/04/23
Flatiron Health Embarks on Strategic Collaboration with Sanofi to Make Clinical Trials More Efficient by Streamlining Data Acquisition at the Point of CareBusiness Wire • 05/01/23
Maze Therapeutics Announces Exclusive Worldwide License Agreement with Sanofi for MZE001, an Oral Substrate Reduction Therapy for the Treatment of Pompe DiseaseBusiness Wire • 05/01/23
Press Release: Hart-Scott-Rodino waiting period expires for Sanofi's acquisition of Provention Bio, Inc.GlobeNewsWire • 04/26/23
Sanofi Announces Launch of AVAXIM® Junior in the UK for Active Immunisation Against Infection Caused by the Hepatitis A Virus in Children Aged 12 Months to 15 YearsBusiness Wire • 04/23/23
Senate legislation would cap insulin at $35 per month for people with private insuranceCNBC • 04/21/23